Innate Immunotherapeutics Limited (IIL) is a medical biotechnology company with offices in Sydney and Auckland. The Company has designed and manufactured a unique immunomodulator microparticle technology that can be used to induce the human immune system to fight certain cancers and infections, or modulate certain immune mechanisms implicated in autoimmune diseases such as Multiple Sclerosis.
None of the content posted on this website should be considered financial advice. Click here for more information. Opinions expressed are those of the respective authors and do not represent the views of Aussie Stock Forums management. Digital Point modules: Sphinx-based search